Abstract is: Clinical Medicine Insights: Oncology is a peer-reviewed open access academic journal focusing on clinical applications of oncology. The journal was founded in 2007, and was originally published by Libertas Academica, but SAGE Publications became the publisher in September 2016. The editor in chief is William Chi-shing Cho.
| P6981 | ACNP journal ID | 3174828 |
| P8375 | Crossref journal ID | 114966 |
| P5115 | Directory of Open Access Journals ID | 1179-5549 |
| P646 | Freebase ID | /m/04g0d6h |
| P8903 | HAL journal ID | 101778 |
| P236 | ISSN | 1179-5549 |
| P7363 | ISSN-L | 1179-5549 |
| P1277 | JUFO ID | 82097 |
| P1055 | NLM Unique ID | 101525771 |
| P856 | official website | http://la-press.com/journal.php?journal_id=42 |
| P10283 | OpenAlex ID | S1031084011 |
| P3181 | OpenCitations bibliographic resource ID | 253153 |
| P8104 | Paperity journal ID | 151896 |
| P12834 | PMC journal ID | 1225 |
| P5966 | SAGE journal ID | onca |
| P7662 | Scilit journal ID | 2894526 |
| P1156 | Scopus source ID | 19700171807 |
| P972 | catalog | Directory of Open Access Journals | Q1227538 |
| P275 | copyright license | Creative Commons Attribution-NonCommercial | Q6936496 |
| P17 | country | United Kingdom | Q145 |
| P495 | country of origin | New Zealand | Q664 |
| P1889 | different from | Clinical medicine. Oncology | Q27722464 |
| P571 | inception | 2007-01-01 | |
| P8875 | indexed in bibliographic review | Scopus | Q371467 |
| Science Citation Index Expanded | Q104047209 | ||
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | oncology | Q162555 |
| P123 | publisher | SAGE Publishing | Q251266 |
| Libertas Academica | Q6541456 | ||
| P1365 | replaces | Clinical medicine. Oncology | Q27722464 |
| P1680 | subtitle | Oncology | |
| P1476 | title | Clinical Medicine | |
| Clinical medicine insights. Oncology |
| Q36327484 | A De Novo Germline APC Mutation (3927del5) in a Patient with Familial Adenomatous Polyposis: Case Report and Literature Review. |
| Q100990847 | A Diagnostic Nomogram of Pathologic Grade for Preoperative Risk Stratification in Upper Tract Urothelial Carcinoma |
| Q37397624 | A Partial Response to Reintroduced Chemotherapy in a Resistant Small Cell Lung Cancer Patient After Priming with RRx-001. |
| Q33903976 | A Phase II Study of S-1 Monotherapy as a First-line Combination Therapy of S-1 Plus Cisplatin as a Second-line Therapy, and Weekly Paclitaxel Monotherapy as a Third-line Therapy in Patients with Advanced Gastric Carcinoma: A Second Report |
| Q38650732 | A Rare Occurrence of Simultaneous Venous and Arterial Thromboembolic Events - Lower Limb Deep Venous Thrombosis and Pulmonary Thromboembolism as Initial Presentation in Acute Promyelocytic Leukemia |
| Q59808563 | A Rare Primary Tumor of the Thyroid Gland: A New Case of Leiomyoma and Literature Review |
| Q58730370 | A Single Institution Experience of Incorporation of Cisplatin into Adjuvant Chemotherapy for Patients With Triple-Negative Breast Cancer of Unknown Mutation Status |
| Q55515089 | A Single-Centre Experience on the Management of Adenosarcoma: A Successful Report of an Integrated Medical and Surgical Approach. |
| Q33574795 | A Study of Use of "PORT" Catheter in Patients with Cancer: A Single-Center Experience |
| Q64250044 | A Surgical Case of Inflammatory Myofibroblastic Tumor of the Liver: Potentially Characteristic Gross Features |
| Q35052548 | A case of late-onset gemcitabine lung toxicity |
| Q42121942 | A case of metastatic mucoepidermoid carcinoma complicated by resistant hypercalcemia |
| Q36981026 | A six-year study of the clinical presentation of cervical cancer and the management challenges encountered at a state teaching hospital in southeast Nigeria |
| Q35193191 | A study of aspects on gender and prognosis in synchronous colorectal cancer |
| Q64249743 | Access to Palliative Care for Cancer Patients Living in a Northern and Rural Environment in Ontario, Canada: The Effects of Geographic Region and Rurality on End-of-Life Care in a Population-Based Decedent Cancer Cohort |
| Q33812162 | Accuracy of [18Fluorine]-Fluoro-2-Deoxy-d-Glucose Positron Emission Tomography-Computed Tomography Response Assessment Following (Chemo)radiotherapy for Locally Advanced Laryngeal/Hypopharyngeal Carcinoma |
| Q41879805 | Achievement of three year remission with bevacizumab and irinotecan in recurrent glioblastoma multiforme: a case report |
| Q38015336 | Acute myeloid leukemia: focus on novel therapeutic strategies. |
| Q35216973 | Ad-REIC Gene Therapy: Promising Results in a Patient with Metastatic CRPC Following Chemotherapy |
| Q91272732 | Adenosquamous Carcinoma of the Pancreas |
| Q41908207 | Advanced Extramammary Paget's Disease of the Groin, Penis, and Scrotum. |
| Q34635176 | Aflibercept in the treatment of metastatic colorectal cancer |
| Q37187292 | Age, Neurological Status MRC Scale, and Postoperative Morbidity are Prognostic Factors in Patients with Glioblastoma Treated by Chemoradiotherapy. |
| Q36344976 | An Unusual Case of Hepatosplenic αβ T-Cell Lymphoma Presenting with Coombs'-Negative Hemolytic Anemia |
| Q36436674 | An unusual instrumentation-related s1 radiculopathy in a patient treated for a primary vertebral (l3) lymphoma. |
| Q98612962 | Anti-EGFR Therapy in Metastatic Small Bowel Adenocarcinoma: Myth or Reality? |
| Q35440552 | Antitumor Efficacy of Intravesical BCG, Gemcitabine, Interferon-α and Interleukin-2 as Mono- or Combination-Therapy for Bladder Cancer in an Orthotopic Tumor Model. |
| Q38163976 | Axitinib: a review of its safety and efficacy in the treatment of adults with advanced renal cell carcinoma. |
| Q33574738 | BCR-ABL V280G Mutation, Potential Role in Imatinib Resistance: First Case Report |
| Q34395314 | Basal cell adenocarcinoma in the tongue: an unusual presentation |
| Q35052538 | Bendamustine: safety and efficacy in the management of indolent non-hodgkins lymphoma |
| Q55001045 | Bevacizumab Eligibility in Patients with Metastatic and Recurrent Cervical Cancer: A Retrospective Review. |
| Q36929502 | Bevacizumab for the treatment of glioblastoma. |
| Q34982777 | Bevacizumab for the treatment of recurrent glioblastoma |
| Q31035723 | Big Data for Cancer Research |
| Q36622902 | C609T Polymorphism of NADPH Quinone Oxidoreductase 1 Correlates Clinical Hematological Toxicities in Lung Cancer Patients Treated with Amrubicin |
| Q42027539 | CD4 Count and Anti Retroviral Therapy for HIV Positive Patients With Cancer in Nigeria -A Pilot Study |
| Q104135412 | CDX2 Expression and Prognostic Factors of Resectable Pulmonary Large Cell Neuroendocrine Carcinoma |
| Q36267710 | Cachexia Index in Advanced Non-Small-Cell Lung Cancer Patients |
| Q34655217 | Cancer-associated thrombosis: an overview |
| Q42758064 | Case Report About Fatal or Near-Fatal Hypersensitivity Reactions to Cetuximab: Anticetuximab IgE as a Valuable Screening Test |
| Q36165461 | Case Studies in the Management of Metastatic Breast Cancer with Eribulin |
| Q99565313 | Central Venous Catheter Thrombosis in Cancer: A Multi-Centre Retrospective Study Investigating Risk Factors and Contemporary Trends in Management |
| Q37082633 | Cervical squamous cell lymph node metastases from an unknown primary site: survival and patterns of recurrence after radiotherapy |
| Q34680316 | Changes in protein level in the cerebrospinal fluid of a patient with cerebral radiation necrosis treated with bevacizumab |
| Q128534836 | Characterization and Survival Benefit of Drug Approvals for Metastatic Prostate Cancer, 2004 to 2022 |
| Q36019028 | Circulating Cytokines and Nitric Oxide are Involved in the Inhibition of Neutrophil Migration in Patients with Uterine Cervical Neoplasia |
| Q38335130 | Cisplatin, cetuximab, and radiation in locally advanced head and neck squamous cell cancer: a retrospective review |
| Q33903965 | Classical and Novel Prognostic Markers for Breast Cancer and their Clinical Significance |
| Q47146357 | Clinical Characteristics of Patients With Renal Cell Carcinoma and Metastasis to the Thyroid Gland |
| Q40357390 | Clinical Efficacy of TroVax in the Treatment of Progressive Castration-resistant Prostate Cancer |
| Q36450307 | Clinical Significance of ALK-1 Gene Abnormalities in Diffuse Large Cell Lymphoma. |
| Q37892934 | Clinical development of cabazitaxel for the treatment of castration-resistant prostate cancer |
| Q35789686 | Clinical efficacy of vorinostat in a patient with leiomyosarcoma |
| Q24611758 | Clinical management of localized colon cancer with capecitabine |
| Q36327481 | Clinical management of pain in advanced lung cancer |
| Q28083844 | Clinicians' expectations for gene-driven cancer therapy |
| Q33393257 | Combination of IFN-α/Gm-CSF as a Maintenance Therapy for Multiple Myeloma Patients After Autologous Stem Cell Transplantation (ASCT): A Prospective Phase II Study |
| Q112640254 | Combining Genetic Mutation and Expression Profiles Identifies Novel Prognostic Biomarkers of Lung Adenocarcinoma |
| Q37226899 | Comparing the Performance of Hybrid Capture II and Polymerase Chain Reaction (PCR) for the Identification of Cervical Dysplasia in the Screening and Diagnostic Settings |
| Q37478505 | Comparing the metal concentration in the hair of cancer patients and healthy people living in the malwa region of punjab, India |
| Q43119235 | Consequences of Different Corticosteroids on Serum Potassium and Prostate-Specific Antigen in Patients Receiving Abiraterone for Castration-Resistant Prostate Cancer: A Retrospective Observational Study |
| Q60045886 | Correlation Between the Sites of Onset of Basal Cell Carcinoma and the Embryonic Fusion Planes in the Auricle |
| Q57069691 | Corrigendum |
| Q104507376 | Cross-Match as an Immuno-Oncological Risk Factor for Hepatocellular Carcinoma Recurrence and Inferior Survival After Living Donor Liver Transplantation: A Call for Further Investigation |
| Q97542023 | Current State of the Art in the Adjuvant Systemic Treatment of Premenopausal Patients With Early Breast Cancer |
| Q42126754 | Current and emerging pharmacotherapies for primary CNS lymphoma |
| Q35155464 | Current and emerging pharmacotherapies for the treatment of relapsed small cell lung cancer |
| Q26830878 | Current and emerging treatment options for patients with relapsed myeloma |
| Q38622907 | Cytogenetic Profile and FLT3 Gene Mutations of Childhood Acute Lymphoblastic Leukemia. |
| Q37152508 | Cytokines and Prognostic Factors in Epithelial Ovarian Cancer |
| Q38087507 | Cytoplasmic Overexpression of HER2: a Key Factor in Colorectal Cancer. |
| Q42430693 | Decitabine induced transient cardiomyopathy: a case report |
| Q26770482 | Delaying Chemotherapy in the Treatment of Hormone Receptor-Positive, Human Epidermal Growth Factor Receptor 2-Negative Advanced Breast Cancer |
| Q40264276 | Development of Interpretable Predictive Models for BPH and Prostate Cancer |
| Q52365121 | Development of Molecularly Targeted Agents and Immunotherapies in Glioblastoma: A Personalized Approach. |
| Q35835939 | Development of myelodysplastic syndrome and acute myeloid leukemia 15 years after hydroxyurea use in a patient with sickle cell anemia |
| Q34203914 | Difference between Luminal A and Luminal B Subtypes According to Ki-67, Tumor Size, and Progesterone Receptor Negativity Providing Prognostic Information |
| Q33574732 | Does Motion Assessment With 4-Dimensional Computed Tomographic Imaging for Non-Small Cell Lung Cancer Radiotherapy Improve Target Volume Coverage? |
| Q90860099 | Early Clinical Outcomes, Patterns of Failure, and Acute Haematologic Toxicity of Image-Guided Volumetric Modulated Arc Therapy (IG-VMAT) in the Definitive Treatment of Locally Advanced Carcinoma Cervix |
| Q34480479 | Early Detection of t(8;21) Chromosomal Translocations During Treatment of PML-RARA Positive Acute Promyelocytic Leukemia: A Case Study |
| Q34052696 | Early Diagnosis of Invasive Aspergillosis in Neutropenic Patients. Comparison between Serum Galactomannan and Polymerase Chain Reaction |
| Q42375631 | Effect of Androgen Deprivation Therapy on Bone Mineral Density in a Prostate Cancer Cohort in New Zealand: A Pilot Study |
| Q35179983 | Effect of tamoxifen and raloxifene on the proliferative activity of the breast epithelium in premenopausal women. |
| Q33574769 | Effects of Serum Leptin and Resistin Levels on Cancer Cachexia in Patients With Advanced-Stage Non-Small Cell Lung Cancer |
| Q34480473 | Efficacy and tolerability after unusually low doses of dasatinib in chronic myeloid leukemia patients intolerant to standard-dose dasatinib therapy. |
| Q38058321 | Efficacy and tolerability of pharmacotherapy options for the treatment of medullary thyroid cancer |
| Q98945589 | Efficacy of Docetaxel Plus Ramucirumab as Palliative Third-Line Therapy Following Second-Line Immune-Checkpoint-Inhibitor Treatment in Patients With Non-Small-Cell Lung Cancer Stage IV |
| Q61805915 | Efficacy of Regorafenib in Metastatic Colorectal Cancer: A Multi-institutional Retrospective Study |
| Q38089497 | Efficacy of bortezomib as first-line treatment for patients with multiple myeloma |
| Q37066657 | Efficacy, Safety and Cost of Regorafenib in Patients with Metastatic Colorectal Cancer in French Clinical Practice. |
| Q35669134 | Emerging Pharmacotherapy for Relapsed or Refractory Hodgkin's Lymphoma: Focus on Brentuximab Vedotin |
| Q37269316 | Emerging options for the management of non-small cell lung cancer |
| Q35740894 | Emerging pharmacotherapies for adult patients with acute lymphoblastic leukemia |
| Q26851272 | Emerging trends in hepatocellular carcinoma: focus on diagnosis and therapeutics |
| Q91531319 | Epidemiological Determinants of Advanced Prostate Cancer in Elderly Men in the United States |
| Q42837525 | Erratum for "metastatic castration-resistant prostate cancer: critical review of enzalutamide" |
| Q46706256 | Erratum in: Review of the Treatment of Non-Small Cell Lung Cancer with Gefitinib. |
| Q112707253 | Evaluation of Pembrolizumab Monotherapy Efficacy in Advanced Non-Small-Cell Lung Cancer by Serial Monitoring of Circulating Tumor DNA Using Next-Generation Sequencing |
| Q38120749 | Evolving pharmacotherapies for the treatment of metastatic melanoma |
| Q128492038 | Excellent Bowel Preparation Quality Is Not Superior to Good Bowel Preparation Quality for Improving Adenoma/Polyp Detection Rate |
| Q92697851 | Expression of Bone Morphogenetic Protein-7 Significantly Correlates With Non-small Cell Lung Cancer Progression and Prognosis: A Retrospective Cohort Study |
| Q41204487 | Expression of concern for "exvivo experiments of human ovarian cancer ascites-derived exosomes presented by dendritic cells derived from umbilical cord blood for immunotherapy treatment". |
| Q45775133 | Factors Affecting Adjuvant Therapy in Stage III Pancreatic Cancer—Analysis of the National Cancer Database |
| Q26743355 | Fertility Risk Assessment and Preservation in Male and Female Prepubertal and Adolescent Cancer Patients |
| Q37607729 | Folate Levels and Polymorphisms in the Genes MTHFR, MTR, and TS in Colorectal Cancer |
| Q92794425 | Follicular Dendritic Cell Sarcoma or Not? A Series of 5 Diagnostically Challenging Cases |
| Q42287385 | Frontline Therapy for Classical Hodgkin Lymphoma by Stage and Prognostic Factors |
| Q28082264 | Functions of Peroxisome Proliferator-Activated Receptor Gamma (PPARγ) in Gynecologic Disorders |
| Q36326176 | Galectin-3 as a Potential Target to Prevent Cancer Metastasis. |
| Q43078253 | Gemcitabine-Induced Pulmonary Toxicity: A Case Report of Pulmonary Veno-Occlusive Disease |
| Q37892932 | Gemcitabine: efficacy in the treatment of advanced stage nonsquamous non-small cell lung cancer |
| Q34657641 | Gene expression profiling for the purposes of biomarker discovery in oral potentially malignant lesions: a systematic review. |
| Q99403999 | Genetic Heterogeneity Between Paired Primary and Brain Metastases in Lung Adenocarcinoma |
| Q26776219 | Glioblastoma Stem Cells as a New Therapeutic Target for Glioblastoma |
| Q98189808 | Gut Microbiota and Response to Immunotherapeutic Drugs in Oncology: More Questions Than Answers |
| Q40966344 | Hemorrhagic cystitis in a patient receiving docetaxel for prostate cancer |
| Q61811561 | Hepatotoxicities Induced by Neoadjuvant Chemotherapy in Colorectal Cancer Liver Metastases: Distinguishing the True From the False |
| Q42430502 | High Dose Rate Brachytherapy in the Treatment of Cervical Cancer: Preliminary Experience with Cobalt 60 Radionuclide Source—A Prospective Study |
| Q112654759 | High expression of cluster of differentiation 276 indicates poor prognosis in glioma |
| Q50054777 | Hodgkin Lymphoma: Differences in Treatment Between Europe and the United States/North America: Evolving Trends in Protocol Therapy |
| Q34412589 | Hormonal Therapeutics Enzalutamide and Abiraterone Acetate in the Treatment of Metastatic Castration-Resistant Prostate Cancer (mCRPC) Post-docetaxel-an Indirect Comparison |
| Q26751021 | Hormone Receptors in Serous Ovarian Carcinoma: Prognosis, Pathogenesis, and Treatment Considerations |
| Q26820863 | Human papilloma virus and squamous cell carcinoma of the anus |
| Q64326968 | Identifying Risk Factors for Morbidity and Mortality in Patients with Primary Head and Neck Cancers in a Nigerian Population |
| Q35607790 | Imatinib mesylate: past successes and future challenges in the treatment of gastrointestinal stromal tumors |
| Q39577914 | Immunotherapy for prostate cancer enters its golden age. |
| Q37607736 | Impact of Gender in Renal Cell Carcinoma: The Relationship of FABP7 and BRN2 Expression with Overall Survival |
| Q92886529 | Improvement of Chemotherapy Solutions Production Procedure in a Hospital Central Chemotherapy Preparation Unit: A Systematic Risk Assessment to Prevent Avoidable Harm in Cancer Patients |
| Q37070898 | Influence of immunotherapy with autologous dendritic cells on innate and adaptive immune response in cancer. |
| Q27027645 | Influenza vaccination in cancer patients undergoing systemic therapy |
| Q35440540 | Inhibitors of Glioma Growth that Reveal the Tumour to the Immune System. |
| Q38362569 | Intraperitoneal follicular dendritic cell sarcoma: role of chemotherapy and bone marrow allotransplantation in locally advanced disease? |
| Q64092287 | Investigation of Complications Following Port Insertion in a Cancer Patient Population: A Retrospective Analysis |
| Q36161313 | Ipilimumab pharmacotherapy in patients with metastatic melanoma |
| Q37305939 | Is Adherence to Imatinib Mesylate Treatment Among Patients with Chronic Myeloid Leukemia Associated with Better Clinical Outcomes in Qatar? |
| Q38080744 | Juxtacortical clavicular chondrosarcoma: diagnostic dilemmas: case report and review of literature. |
| Q42367838 | Key Difficulties Associated with Cancer Biology |
| Q37302533 | Leiomyosarcoma of the splenic vein |
| Q34578623 | Life after breast cancer: dealing with lymphoedema |
| Q41821104 | Long-term treatment of metastatic colorectal cancer with panitumumab |
| Q64073258 | Major Stressful Life Events and Risk of Developing Lung Cancer: A Case-Control Study |
| Q55220804 | Malignant Peritoneal Mesothelioma in the setting of a Ventriculo-Peritoneal Shunt: A novel clinical presentation. |
| Q35789665 | Malignant ovarian tumors with induced expression of carbonyl reductase show spontaneous regression |
| Q35534956 | Management Options in Advanced Prostate Cancer: What is the Role for Sipuleucel-T? |
| Q26752752 | Markers of Response to Antiangiogenic Therapies in Colorectal Cancer: Where Are We Now and What Should Be Next? |
| Q26752780 | Mechanisms Behind the Resistance to Trastuzumab in HER2-Amplified Breast Cancer and Strategies to Overcome It |
| Q33903971 | Melatonin, a promising role in taxane-related neuropathy |
| Q34381852 | Metastatic castration-resistant prostate cancer: critical review of enzalutamide. |
| Q55072444 | Methylation and Gene Expression of BCAT1 and IKZF1 in Colorectal Cancer Tissues. |
| Q34662576 | Micro-cost Analysis of ALK Rearrangement Testing by FISH to Determine Eligibility for Crizotinib Therapy in NSCLC: Implications for Cost Effectiveness of Testing and Treatment |
| Q36688035 | Molecular Analysis of Central Nervous System Disease Spectrum in Childhood Acute Lymphoblastic Leukemia. |
| Q26747796 | Molecular Biology and Clinical Mitigation of Cancer Treatment-Induced Neuropathy |
| Q35219349 | Molecular cytogenetics in childhood acute lymphoblastic leukemia: a hospital-based observational study |
| Q37248406 | Monitoring Metastasis and Cachexia in a Patient with Breast Cancer: A Case Study. |
| Q35117747 | Moving on up: Second-Line Agents as Initial Treatment for Newly-Diagnosed Patients with Chronic Phase CML. |
| Q36611381 | Multicenter Phase II Study of a New Effective S-1 and Irinotecan Combination Schedule in Patients with Unresectable Metastatic or Recurrent Colorectal Cancer |
| Q64084000 | Myoepithelial Cell Carcinoma of the Oral Tongue: Case Report and Review of the Literature |
| Q24569660 | Nelarabine in the treatment of refractory T-cell malignancies |
| Q39736901 | Neonatal systemic juvenile xanthogranuloma with an ominous presentation and successful treatment |
| Q112107395 | Nestin Expression as a Diagnostic and Prognostic Marker in Colorectal Cancer and Other Tumors |
| Q41477162 | Non-Hodgkin Lymphoma of the Stomach in a Patient Treated with Natalizumab |
| Q40298916 | Novel treatments for metastatic cutaneous melanoma and the management of emergent toxicities. |
| Q36318861 | Obesity Correlation With Metastases Development and Response to First-Line Metastatic Chemotherapy in Breast Cancer |
| Q33618680 | Oncology nursing support for safe and effective use of eribulin in metastatic breast cancer |
| Q37916266 | Opioid-induced constipation in advanced illness: safety and efficacy of methylnaltrexone bromide |
| Q64253729 | PAK1 Expression in Pancreatic Cancer: Clinicopathological Characteristics and Prognostic Significance |
| Q34207210 | Paclitaxel as neoadjuvant therapy for high grade angiosarcoma of the spleen: a brief report and literature review. |
| Q39739624 | Paroxysmal nocturnal hemoglobinuria presenting with a left intraventricular thrombus in a patient with prior thymoma and aplastic anemia. |
| Q92856282 | Patterns of Mutation Enrichment in Metastatic Triple-Negative Breast Cancer |
| Q34207205 | Pazopanib for the treatment of patients with advanced renal cell carcinoma |
| Q36679789 | Peripheral helper lymphocytes produce interleukin 12 in cancer patients |
| Q35607787 | Pharmacotherapy options in advanced renal cell carcinoma: what role for pazopanib? |
| Q34575903 | Phase II Clinical Trial of Gefitinib for the Treatment of Chemonaïve Patients with Advanced Non-small Cell Lung Cancer with Poor Performance Status |
| Q41143468 | Pilot study of a clinical pathway implementation in rectal cancer |
| Q55012383 | Precision Medicine in Head and Neck Cancer: Myth or Reality? |
| Q42065463 | Primary Extra-gastrointestinal Stromal Tumor of Retroperitoneum |
| Q33574783 | Primary Squamous Cell Carcinoma of the Stomach |
| Q38153685 | Primary monophasic synovial sarcoma of the kidney: a case report and review of literature |
| Q60913192 | Programmed Death-ligand 1 Expression With Clone 22C3 in Non-small Cell Lung Cancer: A Single Institution Experience |
| Q90476597 | Prospective Analysis of Patients with Metastatic Breast Cancer receiving Eribulin Mesylate as Second or More Lines of Chemotherapy: An Indian Experience |
| Q42734238 | Rapid Increase of the Serum PSA Level in Response to High-Intensity Focused Ultrasound Therapy may be a Potential Indicator of Biochemical Recurrence of Low- and Intermediate-Risk Prostate Cancer |
| Q36929407 | Recent progress in mouse models for tumor suppressor genes and its implications in human cancer |
| Q35835983 | Relapsed and/or Refractory Mantle Cell Lymphoma: What Role for Temsirolimus? |
| Q34982757 | Relationship between plasma glucose levels and malignant uterine cervical neoplasias |
| Q37828399 | Renal cell carcinoma: focus on safety and efficacy of temsirolimus |
| Q26849394 | Resectable Cholangiocarcinoma: Reviewing the Role of Adjuvant Strategies |
| Q26751237 | Resistance to Novel Antiandrogen Therapies in Metastatic Castration-Resistant Prostate Cancer |
| Q99608708 | Results of the Austrian National Lung Cancer Audit |
| Q34789076 | Review of the management of relapsed small-cell lung cancer with amrubicin hydrochloride |
| Q36461805 | Review of the treatment of non-small cell lung cancer with gefitinib |
| Q128688051 | Risk Factors for Distant Metastasis in T3 T4 Rectal Cancer |
| Q128492052 | Risk Models for Predicting the Recurrence and Survival in Patients With Hepatocellular Carcinoma Undergoing Radio-Frequency Ablation |
| Q28075965 | Role of Chemotherapy and Mechanisms of Resistance to Chemotherapy in Metastatic Castration-Resistant Prostate Cancer |
| Q100386166 | Role of Locoregional Treatment in De Novo Stage IV Breast Cancer |
| Q38077764 | Safety and efficacy of cabazitaxel in the docetaxel-treated patients with hormone-refractory prostate cancer. |
| Q35669138 | Safety and efficacy of everolimus in adult patients with neuroendocrine tumors |
| Q37976672 | Safety and efficacy of lenalidomide in relapsed or refractory multiple myeloma |
| Q35789647 | Safety and efficacy of pemetrexed in maintenance therapy of non-small cell lung cancer |
| Q36283958 | Safety and efficacy of pralatrexate in the management of relapsed or refractory peripheral T-cell lymphoma |
| Q38066186 | Safety and efficacy of sunitinib in patients with unresectable pancreatic neuroendocrine tumors |
| Q35052543 | Safety and efficacy of vinorelbine in the treatment of non-small cell lung cancer |
| Q47099465 | Salvage Low Dose Rate Brachytherapy For Recurrent Prostate Cancer After External Beam Radiotherapy: Results From A Single Institution With Focus On Toxicity And Functional Outcomes |
| Q37068367 | Should Sentinel Lymph Node Biopsy for Patients with Early Breast Cancer Be Abandoned? Not So Fast |
| Q35971125 | Small cell lung cancer doubling time and its effect on clinical presentation: a concise review |
| Q26996533 | Spinal osteosarcoma |
| Q35860550 | State-of-the-Art Management of Patients Suffering from Chronic Lymphocytic Leukemia |
| Q55332110 | Successful Second-Line Metronomic Temozolomide in Metastatic Paraganglioma: Case Reports and Review of the Literature. |
| Q93271443 | Summarizing the Evidence Base for Palliative Oncology Care: A Critical Evaluation of the Meta-analyses |
| Q122052997 | Survival Benefits From Adjuvant Lenvatinib for Patients With Hepatocellular Carcinoma and Microvascular Invasion After Curative Hepatectomy |
| Q64325058 | Survival Study of Triple-Negative and Non-Triple-Negative Breast Cancer in a Brazilian Cohort |
| Q35669129 | Survival of patients with squamous cell malignancies of the upper urinary tract |
| Q34982764 | Systemic therapy for elderly patients with gastrointestinal cancer. |
| Q33574744 | Tailored Treatment of Colorectal Cancer: Surgical, Molecular, and Genetic Considerations |
| Q41901542 | Tandem Autologous Stem Cell Transplantation for Multiple Myeloma Patients Based on Response to Their First Transplant-A Prospective Phase II Study |
| Q38114062 | Targeted therapies in the treatment of advanced hepatocellular carcinoma |
| Q26752785 | Targeting Bone Metastases in Metastatic Castration-Resistant Prostate Cancer |
| Q64120080 | The Current Landscape of Treatment in Non-Metastatic Castration-Resistant Prostate Cancer |
| Q112278015 | The Establishment and Experimental Verification of an lncRNA-Derived CD8+ T Cell Infiltration ceRNA Network in Colorectal Cancer |
| Q35835931 | The Evolving Role of Maintenance Therapy Using Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors (EGFR TKIs) in the Management of Advanced Non-Small-Cell Lung Cancer |
| Q97569978 | The Impact of Prolonged Chemotherapy to Surgery Interval and Neoadjuvant Radiotherapy on Pathological Complete Response and Overall Survival in Pancreatic Cancer Patients |
| Q38214084 | The Importance of Multidisciplinary Approach in Early Detection of BAP1 Tumor Predisposition Syndrome: Clinical Management and Risk Assessment |
| Q60919211 | The Nephroprotective Effect of Mannitol in Head and Neck Cancer Patients Receiving Cisplatin Therapy |
| Q42723562 | The Prognostic Role of the Neutrophil-to-Lymphocyte Ratio in Oropharyngeal Carcinoma Treated with Chemoradiotherapy |
| Q97419901 | The Role of Hyponatraemia Before Surgery in Patients With Radical Resected Pancreatic Cancer |
| Q54939982 | The Role of Osimertinib in Treatment Naïve Epidermal Growth Factor Receptor–Mutated Stage IIIB or IV Non–Small-Cell Lung Cancer Patients. |
| Q42734690 | The challenge of metastatic colorectal cancer |
| Q28387851 | The combined influence of oral contraceptives and human papillomavirus virus on cutaneous squamous cell carcinoma |
| Q42213260 | The effectiveness of maintenance pharmacotherapies for non-small cell lung cancer |
| Q24617708 | The emerging role of ofatumumab in the treatment of chronic lymphocytic leukemia |
| Q34982772 | The role of T lymphocytes in cancer patients undergoing immunotherapy with autologous dendritic cells. |
| Q34578630 | The use of patient navigators to improve cancer care for Hispanic patients |
| Q34657144 | The use of pharmacogenomics for selection of therapy in non-small-cell lung cancer |
| Q37014826 | Three Cases of Combined Therapy in Primary Breast Lymphoma (PBL) with Successful Outcomes |
| Q36346309 | Thymidine Phosphorylase Gene Expression in Stage III Colorectal Cancer |
| Q34628607 | Trabectedin: safety and efficacy in the treatment of advanced sarcoma |
| Q43137541 | Transbronchial Dissemination of Squamous Cell Lung Cancer |
| Q41090525 | Transcriptome Analysis of Minimal Residual Disease in Subtypes of Pediatric B Cell Acute Lymphoblastic Leukemia |
| Q35155473 | Transgenic and knockout mice models to reveal the functions of tumor suppressor genes |
| Q35891822 | Trastuzumab for HER2-Positive Metastatic Breast Cancer: Clinical and Economic Considerations |
| Q26785496 | Treating Elderly Patients With Hormone Receptor-Positive Advanced Breast Cancer |
| Q35740882 | Treatment Options in Cushing's Disease |
| Q33985467 | Treatment Options in Metastatic Renal Cell Carcinoma: Focus on mTOR Inhibitors |
| Q36187103 | Treatment-induced bone loss and fractures in cancer patients undergoing hormone ablation therapy: efficacy and safety of denosumab |
| Q34052702 | Trends in cancer immunotherapy |
| Q64954722 | Tumor Size and Overall Survival in Patients With Platinum-Resistant Ovarian Cancer Treated With Chemotherapy and Bevacizumab. |
| Q61806883 | Tumor Treating Fields for Glioblastoma Treatment: Patient Satisfaction and Compliance With the Second-Generation Optune System |
| Q26747792 | Tumor-Infiltrating Lymphocytes in Triple Negative Breast Cancer: The Future of Immune Targeting |
| Q35534962 | Tyrosine kinase inhibitors in the treatment of advanced renal cell carcinoma: focus on pazopanib |
| Q33574761 | Understanding Women's Choice of Mastectomy Versus Breast Conserving Therapy in Early-Stage Breast Cancer |
| Q41894404 | Update on optimal management of acute myeloid leukemia |
| Q38248280 | Update on the Use of l-Asparaginase in Infants and Adolescent Patients with Acute Lymphoblastic Leukemia. |
| Q42134527 | Vandetanib (ZD6474) in the Treatment of Medullary Thyroid Cancer |
| Q38020834 | Vandetanib for the treatment of metastatic medullary thyroid cancer |
| Q33734736 | Vismodegib: the proof of concept in Basal cell carcinoma |
| Q36843044 | Weekly Paclitaxel Versus Three-Weekly Paclitaxel in Recurrent Platinum-Resistant Epithelial Ovarian and Peritoneal Cancers: A Phase III Study |
| Q27009514 | What is the Best Treatment for a Cancer Patient with Thrombosis? |
| Q27722464 | Clinical medicine. Oncology | replaced by | P1366 |
| Q27722464 | Clinical medicine. Oncology | different from | P1889 |
| Clinical Medicine Insights: Oncology | wikipedia |
Search more.